Figures & data
Figure 1. Characterizations of ZnO nanoparticles. (A) Morphology of ZnO nanoparticles; (B) Size distribution and (C) zeta potential of ZnO nanoparticles dissolved in DMEM.
![Figure 1. Characterizations of ZnO nanoparticles. (A) Morphology of ZnO nanoparticles; (B) Size distribution and (C) zeta potential of ZnO nanoparticles dissolved in DMEM.](/cms/asset/8efe08ea-553e-4817-b79e-06887fe213b9/ianb_a_1446018_f0001_b.jpg)
Figure 2. Changes of cell morphology after exposure to different concentrations of ZnO nanoparticles for 6 h. (A) Control cells; (B) cells treated with 31.25; (C) 62.5 and (D) 125.0 μmol/l ZnO nanoparticles, respectively. Bar =20 μm.
![Figure 2. Changes of cell morphology after exposure to different concentrations of ZnO nanoparticles for 6 h. (A) Control cells; (B) cells treated with 31.25; (C) 62.5 and (D) 125.0 μmol/l ZnO nanoparticles, respectively. Bar =20 μm.](/cms/asset/5dd7d1a2-7ad1-410e-b68c-30ac0a9395ef/ianb_a_1446018_f0002_b.jpg)
Figure 3. Effects of different concentrations of ZnO nanoparticles on 661 W cells for 6 h. (A) Alterations of cytochrome c levels in cell culture supernatants; (B) Cellular ATP content; (C) Collapse of mitochondrial membrane potential; (D) Analysis of intracellular ROS levels; (E) Alterations of intracellular total antioxidant enzyme activities and (F) Apoptosis/necrosis analysis. Results are shown as mean ± SD of three independent experiments. *p < .05 and **p < .01 versus relevant control.
![Figure 3. Effects of different concentrations of ZnO nanoparticles on 661 W cells for 6 h. (A) Alterations of cytochrome c levels in cell culture supernatants; (B) Cellular ATP content; (C) Collapse of mitochondrial membrane potential; (D) Analysis of intracellular ROS levels; (E) Alterations of intracellular total antioxidant enzyme activities and (F) Apoptosis/necrosis analysis. Results are shown as mean ± SD of three independent experiments. *p < .05 and **p < .01 versus relevant control.](/cms/asset/544b8c4d-e8db-4891-8108-f03678eb016b/ianb_a_1446018_f0003_b.jpg)
Table 1. Summary of label-free quantitative proteomic profiling results.
Figure 5. Determinations of Bax, Bcl-2 and Caspase 3 expressions at mRNA and protein levels after exposure to different concentrations of ZnO nanoparticles for 6 h. (A), (B) and (C) were determined using quantitative PCR, (D), (E) and (F) were determined by ELISA. *p < .05 and **p < .01 versus relevant controls.
![Figure 5. Determinations of Bax, Bcl-2 and Caspase 3 expressions at mRNA and protein levels after exposure to different concentrations of ZnO nanoparticles for 6 h. (A), (B) and (C) were determined using quantitative PCR, (D), (E) and (F) were determined by ELISA. *p < .05 and **p < .01 versus relevant controls.](/cms/asset/bf6aa5c7-2fde-4ae3-8219-14b662c42cad/ianb_a_1446018_f0005_b.jpg)
Figure 6. Gene ontology (GO) analysis of differentially expressed proteins. Categorization of differentially expressed proteins was analyzed according to molecular function and biological progress.
![Figure 6. Gene ontology (GO) analysis of differentially expressed proteins. Categorization of differentially expressed proteins was analyzed according to molecular function and biological progress.](/cms/asset/30741812-3d0f-4392-a1b3-2a1c025f994c/ianb_a_1446018_f0006_b.jpg)